Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PathoFinder has developed and commercialized proprietary multiplex molecular diagnostic assays for infectious disease detection. Their CE-IVD marked products can simultaneously identify up to 25 viral and bacterial pathogens in a single test using real-time or capillary electrophoresis-based PCR. The company’s solutions are validated for clinical use in Europe and other regions outside North America. They have four main syndromic panels on the market, including a COVID‑19 panel launched during the pandemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PathoFinder.